Clinical Trial Update: Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections [Phase 4]

View source ↗

Summary

Phase 4 trial of Cipro XR completed, evaluating therapeutic response and symptom relief in urinary tract infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Cipro XR (ciprofloxacin)

Snippet

Sponsor: Bayer | Conditions: Urinary Tract Infection | Phase 4 | Status: COMPLETED